Please select the option that best describes you:
Would you offer adjuvant therapy for a patient with stage I high risk invasive mole after hysterectomy?
WHO score 8, for initial beta hCG, tumor size, and failure to respond to inpatient high dose MTX therapy (given as patient originally desired fertility sparing surgery)
Answer from: at Community Practice
Great question! For this patient’s unique situation, although adjuvant chemotherapy is entirely appropriate, I believe it may not be necessary. The decision to offer adjuvant therapy may be cautiously delayed pending her immediate post-hysterectomy hCG levels. If there is a rapid decline in hC...
Sign in or Register to read more